AArkstore enterprise 7th Novenber 2014
Gr aves Disease Ther apeutics - Pipeline Assessment and Market Forecast to 2019 Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60318/graves-disease-therapeuticspipeline-assessment-and-market-forecast Published: Feb 2012 | No. Of Pages: 58 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
Graves Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019
Summary the industry analysis specialist, has released its new report, Graves Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019. The report is an essential source of information and analysis on the global Graves Disease Therapeutics market. The report identifies the key trends shaping and driving the global Graves Disease Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Graves Disease Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope The report provides information on the key drivers and challenges of the Graves Disease Therapeutics market. Its scope includes -
Website : http://www.aarkstore.com/
AArkstore enterprise - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Graves Disease Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Graves Disease Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Graves Disease Therapeutics market. - Analysis of key recent licensing and partnership agreements in Graves Disease Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Graves Disease Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Graves Disease Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - Whats the next big thing in the global Graves Disease Therapeutics market landscape? Identify, understand and capitalize.
Website : http://www.aarkstore.com/
AArkstore enterprise Tables Of Contents 2 Introduction 6 2.1 Overview 6 2.1.1 Biosynthesis of Thyroid Hormones 6 2.2 Epidemiology 7 2.3 Etiology 8 2.4 Risk Factors 9 2.5 Signs and Symptoms 9 2.6 Diagnosis 11 2.6.1 Laboratory Tests 11 2.6.2 Imaging Tests 12 2.7 Treatment 12 2.7.1 Antithyroid drugs 12 2.7.2 Radioactive Iodine (RAI) Therapy 13 2.7.3 Thyroid Surgery 13 2.7.4 Treatment for Graves Ophthalmology 13 2.8 GlobalData Pipeline Report Guidance 14 3 Graves Disease Therapeutics - Market Characterization 15 3.1 Major Markets, Market Size (2006 - 2011) 15 3.2 Major Markets, Market Forecast (2011 - 2019) 17 3.3 US Market Size (2006 - 2011) 19 3.4 US Market Forecast (2011 - 2019) 20
Website : http://www.aarkstore.com/
AArkstore enterprise 3.5 UK Market Size (2006 - 2011) 21 3.6 UK Market Forecast (2011 - 2019) 22 3.7 Germany Market Size (2006 - 2011) 23 3.8 Germany Market Forecast (2011 - 2019) 24 3.9 Italy Market Size (2006 - 2011) 25 3.10 Italy Market Forecast (2011 - 2019) 26 3.11 France Market Size (2006 - 2011) 27 3.12 France Market Forecast (2011 - 2019) 28 3.13 Spain Market Size (2006 - 2011) 29 3.14 Spain Market Forecast (2011 - 2019) 30 3.15 Japan Market Size (2006 - 2011) 31 3.16 Japan Market Forecast (2011 - 2019) 32 3.17 Drivers and Barriers for Graves Disease Therapeutic Market 33 3.17.1 Drivers for the Graves Disease Market 33 3.17.2 Barriers for Graves disease Market 33 3.18 Opportunity and Unmet Need 35 3.19 Key Takeaway 35 4 Graves Disease Market - Competitive Assessment 36 4.1 Overview 36 4.1.1 Strategic Competitor Assessment 36 4.2 Graves Disease Marketed Products Profile 37 4.2.1 Antithyroid drugs 37 4.2.2 Radioactive Iodine Therapy 38
Website : http://www.aarkstore.com/
AArkstore enterprise 4.2.3 Beta Blockers 38 4.3 Key Takeaway 38 5 Graves Disease - Pipeline Assessment 39 5.1 Overview 39 5.2 Strategic Pipeline Assessment 39 5.3 Graves Disease Pipeline Analysis - Pipeline by Clinical Phase of Development 40 5.3.1 Graves Disease Therapeutics - Phase II/III Clinical Pipeline 40 5.3.2 Graves Disease Therapeutics - Phase I Clinical Pipeline 41 5.3.3 Graves disease Therapeutics - Discovery Pipeline 41 5.4 Graves Disease Pipeline by Mechanism of Action 41 5.5 Graves Disease Technology Trends Analytical Framework 42 5.6 Molecule Profile for Drug under Late-stage Clinical Development 43 5.6.1 Rituxan/MabThera (rituximab) 43 5.7 Key Takeaway 43 6 Graves Disease Therapeutics - Clinical Trials Mapping 44 6.1 Clinical Trials Mapping by Region/Country 44 6.2 Clinical Trials Mapping by Phase 45 6.3 Clinical Trials Mapping by Trial Status 46 6.4 Clinical Trials Mapping by Overall Sponsors 47 6.5 Clinical Trials Mapping by Sponsors 48 7 Graves Disease Therapeutics - Implications for Future Competition 49 7.1 Future Market Competition Scenario 49 8 Global Graves Disease Therapeutics - Future Players in The Market 50
Website : http://www.aarkstore.com/
AArkstore enterprise 8.1 Introduction 50 8.2 GlaxoSmithKline 50 8.2.1 Company Overview 50 8.2.2 Financial Performance: 50 8.2.3 Business Description 51 8.3 Apitope International NV 52 8.3.1 Company Overview 52 9 Global Graves Disease Therapeutics Appendix 53 9.1 Definitions 53 9.2 Acronyms 53 9.3 Methodology 54 9.3.1 Coverage 54 9.3.2 Secondary Research 54 9.3.3 Forecasting 54 9.3.4 Primary Research 56 9.3.5 Expert Panel Validation 57 9.4 Contact Us 57 9.5 Disclaimer 57 9.6 Sources 57
List Of Tables Table 1: Prevalence of Prevalence, 2011 7 Table 2: Graves Disease Therapeutics, Global, Market Revenue ($m), 2006 - 2011 15
Website : http://www.aarkstore.com/
AArkstore enterprise Table 3: Graves Disease Therapeutics, Global, Revenue Forecasts ($m), 2011 - 2019 17 Table 4: Graves Disease Therapeutics, The US, Market Historical Revenue ($m), 2006 - 2011 19 Table 5: Graves Disease Therapeutics, The US, Revenue Forecasts ($m), 2011 - 2019 20 Table 6: Graves Disease Therapeutics, The UK, Market Historical Revenue ($m), 2006 - 2011 21 Table 7: Graves Disease Therapeutics, The UK, Revenue Forecasts ($m), 2011 - 2019 22 Table 8: Graves Disease Therapeutics, Germany, Market Revenue ($m), 2006 - 2011 23 Table 9: Graves Disease Therapeutics, Germany, Revenue Forecasts ($m), 2011 - 2019 24 Table 10: Graves Disease Therapeutics, Italy, Market Revenue ($m), 2006 - 2011 25 Table 11: Graves Disease Therapeutics, Italy, Revenue Forecasts ($m), 2011 - 2019 26 Table 12: Graves Disease Therapeutics, France, Market Revenue ($m), 2006 - 2011 27 Table 13: Graves Disease Therapeutics, France, Revenue Forecasts ($m), 2011 - 2019 28 Table 14: Graves Disease Therapeutics, Spain, Market Revenue ($m), 2006 - 2011 29 Table 15: Graves Disease Therapeutics, Spain, Revenue Forecasts ($m), 2011 - 2019 30 Table 16: Graves Disease Therapeutics, Japan, Market Revenue ($m), 2006 - 2011 31 Table 17: Graves Disease Therapeutics, Japan, Revenue Forecasts ($m), 2011 - 2019 32 Table 18: Graves Disease Therapeutics - Phase II/III Clinical Pipeline, 2011 40 Table 19: Graves Disease Therapeutics - Phase I Clinical Pipeline, 2011 41 Table 20: Graves Disease Therapeutics - Discovery Pipeline, 2011 41 Table 21: Graves Disease Clinical Trials by Region - Number, 2011 44 Table 22: Graves Disease Clinical Trials by Phase, 2011 45 Table 23: Graves Disease Clinical Trials by Status , 2011 46 Table 24: Graves Disease Clinical Trials by Overall Sponsors, 2011 47 Table 25: Graves Disease Clinical Trials by Sponsors, 2011 48
Website : http://www.aarkstore.com/
AArkstore enterprise List Of Figures Figure 1: Pathophysiology of Graves Disease 8 Figure 2: Different Forms of Pretibial Myxedema Seen in Patients of Graves Disease 10 Figure 3: Graves Ophthalmology 10 Figure 4: Graves Disease Therapeutics, Global, Market Revenue ($m), 2006 - 2011 15 Figure 5: Graves Disease Therapeutics, Market Share (%), 2011 16 Figure 6: Graves Disease Therapeutics, Global, Revenue Forecasts ($m), 2011 - 2019 17 Figure 7: Graves Disease Therapeutics, Forecast Market Share (%), 2019 18 Figure 8: Graves Disease Therapeutics, The US, Market Revenue ($m), 2006 - 2011 19 Figure 9: Graves Disease Therapeutics, The US, Revenue Forecasts ($m), 2011 - 2019 20 Figure 10: Graves Disease Therapeutics, The UK, Market Revenue ($m), 2006 - 2011 21 Figure 11: Graves Disease Therapeutics, The UK, Revenue Forecasts ($m), 2011 - 2019 22 Figure 12: Graves Disease Therapeutics, Germany, Market Revenue ($m), 2006 - 2011 23 Figure 13: Graves Disease Therapeutics, Germany, Revenue Forecasts ($m), 2011 - 2019 24 Figure 14: Graves Disease Therapeutics, Italy, Market Revenue ($m), 2006 - 2011 25 Figure 15: Graves Disease Therapeutics, Italy, Revenue Forecasts ($m), 2011 - 2019 26 Figure 16: Graves Disease Therapeutics, France, Market Revenue ($m), 2006 - 2011 27 Figure 17: Graves Disease Therapeutics, France, Revenue Forecasts ($m), 2011 - 2019 28 Figure 18: Graves Disease Therapeutics, Spain, Market Revenue ($m), 2006 - 2011 29 Figure 19: Graves Disease Therapeutics, Spain, Revenue Forecasts ($m), 2011 - 2019 30 Figure 20: Graves Disease Therapeutics, Japan, Market Revenue ($m), 2006 - 2011 31 Figure 21: Graves Disease Therapeutics, Japan, Revenue Forecasts ($m), 2011 - 2019 32
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 22: Graves Disease Therapeutic Market - Drivers and Barriers 34 Figure 23: Opportunity and Unmet Need in the Graves Disease Therapeutic Market 35 Figure 24: Strategic Competitor Assessment of Marketed Products for Graves Disease, 2011 37 Figure 25: Pipeline Products by Phase of Clinical Development, 2011 39 Figure 26: Pipeline Products by indication 40 Figure 27: Graves Disease Therapeutics Pipeline by Phase of Clinical Development, 2011 40 Figure 28: Graves Disease Therapeutics - Clinical Pipeline by Mechanism Of Action, 2011 41 Figure 29: Technology Trends Analytical Framework of The Graves Disease Pipeline, 2011 42 Figure 30: Technology Trends Analytical Framework of The Graves Disease Pipeline - Description, 2011 42 Figure 31: Graves Disease Clinical Trials by Region, 2011 44 Figure 32: Graves Disease Clinical Trials by Phase, 2011 45 Figure 33: Graves Disease Clinical Trials by Status, 2011 46 Figure 34: Graves Disease Clinical Trials by Sponsors, 2011 47 Figure 35: Graves Disease Clinical Trials by Prominent Sponsors, 2011 48 Figure 36: Implications for Future Market Competition in the Graves Disease Market, 2011 49 Figure 37: Graves Disease Therapeutics, Clinical Pipeline by Company, 2011 50 Figure 38: GlobalData Market Forecasting Model 56
Related reports: Dr. Falk Pharma GmbH - Product Pipeline Review - 2014 Altor BioScience Corporation - Product Pipeline Review - 2014 Apitope International NV - Product Pipeline Review - 2014 Diabetology Limited - Product Pipeline Review - 2014 Bioo Therapeutics - Product Pipeline Review - 2014
Website : http://www.aarkstore.com/
AArkstore enterprise AntiCancer, Inc. - Product Pipeline Review - 2014 EndoCeutics, Inc. - Product Pipeline Review - 2014 Interprotein Corporation - Product Pipeline Review - 2014 REGiMMUNE Corporation - Product Pipeline Review - 2014 ViroMed Co., Ltd. - Product Pipeline Review - 2014
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60318/graves-diseasetherapeutics-pipeline-assessment-and-market-forecast
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom
Website : http://www.aarkstore.com/
AArkstore enterprise Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/